Intellipharmaceutics International Inc
Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, car… Read more
Intellipharmaceutics International Inc (IPCIF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of August 2023: -0.019x
Based on the latest financial reports, Intellipharmaceutics International Inc (IPCIF) has a cash flow conversion efficiency ratio of -0.019x as of August 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($240.83K) by net assets ($-12.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Intellipharmaceutics International Inc - Cash Flow Conversion Efficiency Trend (2015–2022)
This chart illustrates how Intellipharmaceutics International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Intellipharmaceutics International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Intellipharmaceutics International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MILA RESOUR. PLC LS-01
F:HN0
|
N/A |
|
Thunderbird Resources Ltd
AU:THB
|
-0.043x |
|
Real Heart
ST:HEART
|
-0.026x |
|
Wahana Ottomitra Multiartha
JK:WOMF
|
-0.049x |
|
CJ Century Logistics Holdings Bhd
KLSE:7117
|
0.091x |
|
Plasson Indus
TA:PLSN
|
0.068x |
|
Vertex Energy Inc
NASDAQ:VTNR
|
0.067x |
|
Euromedis Groupe SA
PA:ALEMG
|
0.048x |
Annual Cash Flow Conversion Efficiency for Intellipharmaceutics International Inc (2015–2022)
The table below shows the annual cash flow conversion efficiency of Intellipharmaceutics International Inc from 2015 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-11-30 | $-10.58 Million | $-1.39 Million | 0.131x | -56.51% |
| 2021-11-30 | $-8.16 Million | $-2.46 Million | 0.302x | +1799.71% |
| 2020-11-30 | $-6.31 Million | $112.11K | -0.018x | -100.98% |
| 2019-11-30 | $-3.69 Million | $-6.66 Million | 1.805x | +159.19% |
| 2018-11-30 | $4.10 Million | $-12.51 Million | -3.049x | +80.70% |
| 2017-11-30 | $386.38K | $-6.11 Million | -15.802x | -182.01% |
| 2016-11-30 | $1.12 Million | $-6.25 Million | -5.603x | -120.40% |
| 2015-11-30 | $-137.69K | $-3.78 Million | 27.469x | -- |